BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Global Biodefense
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201201
DTEND;VALUE=DATE:20201203
DTSTAMP:20201127T195218Z
CREATED:20201127T195203Z
LAST-MODIFIED:20201127T195218Z
UID:48069-1606780800-1606953599@globalbiodefense.com
SUMMARY:Security of America’s Medical Product Supply Chain - Public Workshop
DESCRIPTION:The National Academies’ Committee on Security of America’s Medical Product Supply Chain will host its second meeting and a public workshop from December 1-3\, 2020. \nThe public workshop will be held on December 1 (12:00pm to 3:30pm) and December 2 (11:30am to 3:30pm). \nObjectives for the public workshop include the following: \n\nConsider on-the-ground perspectives from end users of the medical supply chain (e.g.\, patients\, clinicians\, health systems) when it comes to:\n\nwhat makes a medical product critical/essential\noutcome measures that matter to end users\napproaches to mitigate the impact of failures in the medical supply chain\n\n\nExamine current lists of “critical/essential” medical products with attention to how these lists were formulated and how they are used to inform decisions;\nDiscuss key considerations for the formulation of a unified list of critical medical products;\nConsider tactical approaches for improving supply chain resiliency.\n\nBackground\nIn response to the CARES Act\, the National Academies of Sciences\, Engineering\, and Medicine will establish an ad hoc committee to conduct a study to examine the security of the United States medical product supply chain. The committee will assess and evaluate the dependence of the United States on critical drugs and devices that are sourced or manufactured outside of the United States and provide recommendations to improve the resiliency of the medical supply chain. \nThe committee will: \n1) assess and evaluate the dependence of the United States\, including the private commercial sector\, States\, and the Federal Government\, on critical drugs and devices that are sourced or manufactured outside of the United States\, which may include an analysis of: \n\nthe supply chain of critical drugs and devices of greatest priority to providing health care;\nany potential public health security or national security risks associated with reliance on critical drugs and devices sourced or manufactured outside of the United States\, which may include responses to previous or existing shortages or public health emergencies\, such as infectious disease outbreaks\, bioterror attacks\, and other public health threats;\nany existing supply chain information gaps\, as applicable; and\npotential economic impact and other considerations associated with increased domestic manufacturing; and\n\n2) provide recommendations to improve the resiliency of the supply chain for critical drugs and devices and to address any supply vulnerabilities or potential disruptions of such products that would significantly affect or pose a threat to public health security or national security\, as appropriate\, which may include strategies to: \n\npromote supply chain redundancy and contingency planning;\nencourage domestic manufacturing\, including consideration of economic impacts\, if any;\nimprove supply chain information gaps;\nimprove planning considerations for medical product supply chain capacity during public health emergencies; and\npromote the accessibility of such drugs and devices.
URL:https://globalbiodefense.com/event/security-of-americas-medical-product-supply-chain-public-workshop/
CATEGORIES:Webinar-Webcast,Workshop
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201201T170000
DTEND;TZID=America/New_York:20201201T180000
DTSTAMP:20201127T194745Z
CREATED:20201127T194745Z
LAST-MODIFIED:20201127T194745Z
UID:48067-1606842000-1606845600@globalbiodefense.com
SUMMARY:Assessment of the SBIR and STTR Programs at NIH - Meeting 8
DESCRIPTION:The Eighth Meeting of the Committee on the Assessment of the SBIR and STTR Programs at the National Institutes of Health (NIH) will be held virtually on December 1\, 2020. \nWhat is the effectiveness of the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs at the National Institutes of Health (NIH)? An ad hoc committee will conduct a study of the economic and healthcare benefits of the SBIR and STTR programs at NIH and the effectiveness of the enabling strategies NIH has employed to enhance the programs. \nMeeting will be held via Zoom. This meeting will be open in its entirety. \nPlease write to step@nas.edu to attend. \nBackground\nIn response to a Congressional mandate\, an ad hoc committee will conduct a study of the economic and healthcare benefits of the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs at the National Institutes of Health (NIH) and the effectiveness of the enabling strategies NIH has employed to enhance the programs. The committee will draw on published research; existing\, available data; and case studies\, and convene a series of meetings. Specifically and to the extent that data are available\, the committee will examine: \nSBIR effectiveness: Leveraging existing NIH evaluation strategies and data that are made available to the committee\, case studies\, and other available data\, the committee will examine whether the NIH SBIR Program is fulfilling the requirements of the enabling legislation; and study the impact and effectiveness of the enabling strategies NIH has employed to enhance the program\, including\, but not limited to\, technical and business assistance programs and the Phase IIB program. \nSTTR effectiveness: Leveraging existing NIH evaluation strategies and data that are made available\, the committee will study how the NIH STTR Program\, including the strategies designed to enable academic entrepreneurship and innovation\, has fulfilled the requirements of the enabling legislation\, including: \n\nA review of the collaborations created between small businesses and research institutions\, including an evaluation of the effectiveness of the program in stimulating new collaborations and any obstacles that may prevent or inhibit the creation of such collaborations.\nAn evaluation of the effectiveness of the program at transferring federally funded technology and capabilities toward commercialization.\nAn examination of the non-economic impacts to businesses including measures of demographics\, participation of underrepresented groups\, and knowledge of the technical and business requirements of life science sector commercialization.\nAn analysis of whether STTR funds could be employed more effectively by the NIH STTR program to achieve the goals of the enabling legislation.
URL:https://globalbiodefense.com/event/assessment-of-the-sbir-and-sttr-programs-at-nih-meeting-8/
CATEGORIES:Webinar-Webcast,Workshop
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201203T110000
DTEND;TZID=America/New_York:20201203T143000
DTSTAMP:20201127T210413Z
CREATED:20201127T210413Z
LAST-MODIFIED:20201127T210413Z
UID:48071-1606993200-1607005800@globalbiodefense.com
SUMMARY:Lessons Learned in Health Professions Education from the COVID-19 Pandemic
DESCRIPTION:A planning committee of the National Academies of Sciences\, Engineering\, and Medicine will organize and conduct a 1-day public workshop on Dec. 3\, 2020 to explore lessons learned in grand challenges facing health professions education (HPE) stemming from the COVID-19 pandemic and how those positive and negative experiences might inform development of sustainable improvements in the value\, effectiveness\, and impact of HPE. The planning committee will bring together educators\, students\, administrators\, and health professionals to share ideas\, stories\, and data in an effort to discuss the future of HPE by learning from past experiences. Invited presentations and discussions will involve global audiences in topics such as: \n\nExamples and evaluation of online education;\nInnovations in interprofessional education and learning opportunities within the social determinants of health and mental health;\nImpacts on pre-clinical and clinical education;\nRegulatory and accreditation changes affecting HPE; and\nStress and workload on students and faculty.\n\nRegister here.
URL:https://globalbiodefense.com/event/lessons-learned-in-health-professions-education-from-the-covid-19-pandemic/
CATEGORIES:Webinar-Webcast,Workshop
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201207
DTEND;VALUE=DATE:20201210
DTSTAMP:20201127T212644Z
CREATED:20201127T212644Z
LAST-MODIFIED:20201127T212644Z
UID:48073-1607299200-1607558399@globalbiodefense.com
SUMMARY:DoD Materials Science and Engineering in a Post-Pandemic World: A Workshop
DESCRIPTION:How has COVID-19 affected Department of Defense materials and manufacturing capabilities\, and what does this mean for future workforce needs? The National Academies invites you to explore Materials Science and Engineering in a Post-Pandemic World as part of a three-day virtual public workshop December 7-9\, 2020. \nWorkshop topics will include 1) how COVID-19 is impacting and is expected to impact DOD materials and manufacturing capabilities; 2) how the current materials and manufacturing workforce is affected; 3) efforts being considered to address future DOD materials and manufacturing needs; and 4) the future of the DOD workforce pipeline. \nLearn more and register: https://bit.ly/dod-post-pandemic-mfc \n 
URL:https://globalbiodefense.com/event/dod-materials-science-and-engineering-in-a-post-pandemic-world-a-workshop/
CATEGORIES:Webinar-Webcast,Workshop
LOCATION:
END:VEVENT
END:VCALENDAR